PAGE OF PAGES AWARDICONTRACT 1. THIS CONTRACT IS A RATED ORDER UNDER DPAS (15 CFR 350) 1 I 28 2. CONTRACT (Prsc. Insr. 1denr.l NO. 3..EFFECTIVE DATE 4. REQUlSlTlONlPURCHASE REQUESTIPROJECT NO. HHS’0100200700032c I 1 6. ISSUED BY CODE1 ADMINISTERED BY...Biocryst Pharmaceuticals Inc • August 9th, 2007 • Biological products, (no disgnostic substances)
This project from the Department of Health and Human Services (HHS) through the Office of Public Health Emergency Medical Countermeasures (OPHEMC) within the Office of Public Health Emergency Preparedness (OPHEP) provides incremental multi-year funding for cost-reimbursable contracts for the advanced development of prophylactic and therapeutic drugs against pandemic and seasonal influenza viral pathogens leading towards U.S.-licensure. The antiviral drugs of interest may include any compound or drug providing anti-influenza. These may include synthetic chemical compounds, snRNAi, polyclonal/monoclonal antibody cocktails or other drugs, which could be used in the treatment and/or prophylaxis to decrease the morbidity and mortality associated with seasonal and pandemic influenza. The objective of this project is to facilitate the development and U.S.-licensure of antiviral drugs effective as prophylactic/therapeutic agents against influenza virus infection.
AMENDMENT OF BIOCRYST RIGHTS AGREEMENTRights Agreement • August 9th, 2007 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances)
THIRD AMENDMENT TO LEASE AGREEMENTLease Agreement • August 9th, 2007 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances)
THIS THIRD AMENDMENT TO LEASE AGREEMENT, hereafter referred to as the “Agreement” is made and entered into on this 7th day of August, 2007, by and between Riverchase Capital LLC, a Florida limited liability company, and Stow Riverchase, LLC, a Florida limited liability company, as successor landlord to RBP, LLC, an Alabama limited liability company, hereafter referred to as collectively “Landlord” and BioCryst Pharmaceuticals, Inc. hereafter referred to as “Tenant”.
